孕期糖尿病:揭示从怀孕到产后视角的母亲健康动态
Marina Mora-Ortiz1,2,3, Lorenzo Rivas-García4,5
1Lipids and Atherosclerosis Unit, Internal Medicine, Reina Sofia University Hospital, Córdoba, Andalucía, 14004, Spain.
Open research Europe
|October 2, 2024
概括
孕期糖尿病 (GDM) 是一种常见的妊娠并发症,其发病率不断上升,对母亲和婴儿的健康有重大风险. 需要更多的研究来了解其长期影响和改善结果.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 孕期糖尿病 (GDM) 是最常见的妊娠并发症,影响全球5-25%的怀孕.
- 它的流行率正在增加,反映了糖尿病和肥胖的全球趋势.
- 诊断标准在国际上有所不同,使研究和临床比较复杂化.
研究的目的:
- 批判性地审查目前关于GDM流行,诊断挑战和健康影响的研究.
- 确定了解GDM对母亲和后代的长期后果的知识差距.
- 促进进一步的研究,以改善母亲和儿童健康结果.
主要方法:
- 关于GDM研究的综合文献综述.
- 分析关于GDM流行和诊断的当前数据.
- 评估对母亲和儿童的短期和长期健康影响.
主要成果:
- GDM对短期和长期健康构成重大风险,包括心血管疾病的增加和母亲患2型糖尿病 (T2DM) 的70%风险.
- 后代面临儿童肥胖和代谢综合征 (20-50%) 的高风险.
- 关于GDM受影响的女性易患T2DM的代谢特征以及对后代的持久健康影响的研究有限.
结论:
- 孕婴儿瘤是一个关键的公共卫生问题,对母亲和后代的健康有重大影响.
- 关于GDM的长期代谢影响和潜在机制,仍然存在重大知识差距.
- 进一步的研究对于解决诊断不一致性和减轻与GDM相关的持续健康风险至关重要.
相关概念视频
Pathophysiology of Diabetes
894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
515
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243


